Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

Autor:	Peter Iglauer, Sabine Riethdorf, Genny Buson, Markus Tiemann, Lars-Arne Berger, Kelli Bramlett, Ru Cao, Claudio Forcato, Ronald Simon, Martin Reck, Nicolò Manaresi, Isabel Ben-Batalla, Markus Falk, Melanie Janning, Carsten Bokemeyer, Guido Sauter, S. Schatz, Harriet Wikman, Janna-Lisa Velthaus, Annkathrin Hanssen, Sonja Loges, Klaus Pantel
Rok vydání:	2018
Předmět:	0301 basic medicine Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty Lung Neoplasms Met amplification Antineoplastic Agents Drug resistance Neoplasm genetics 03 medical and health sciences 0302 clinical medicine Crizotinib Internal medicine Carcinoma Non-Small-Cell Lung medicine Humans Anaplastic Lymphoma Kinase business.industry ALK-Positive Gene Amplification Middle Aged Proto-Oncogene Proteins c-met Neoplastic Cells Circulating Prognosis 030104 developmental biology Drug Resistance Neoplasm 030220 oncology & carcinogenesis Female business Cell-Free Nucleic Acids medicine.drug
Zdroj:	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(12)
ISSN:	1556-1380
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f905a1a403c71779f7c0094fec4b85 https://pubmed.ncbi.nlm.nih.gov/30205165 Zobrazit plný text záznamu